Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian T Tsuji

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|March 13, 2013
Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing designCornelia B Landersdorfer, Neang S Ly, Hongmei Xu, et al.
The Journal of Antibiotics|June 9, 2016
Impact of Staphylococcus aureus accessory gene regulator (agr) system on linezolid efficacy by profiling pharmacodynamics and RNAIII expressionRachel L Soon, Justin R Lenhard, Irene Reilly, et al.
Diagnostic Microbiology and Infectious Disease|February 6, 2008
Evaluation of daptomycin, telavancin, teicoplanin, and vancomycin activity in the presence of albumin or serumBrian T Tsuji, Steven N Leonard, Paul R Rhomberg, et al.
Annals of Clinical Microbiology and Antimicrobials|May 24, 2011
Impact of accessory gene regulator (agr) dysfunction on vancomycin pharmacodynamics among Canadian community and health-care associated methicillin-resistant Staphylococcus aureusBrian T Tsuji, Robert D MacLean, Linda D Dresser, et al.
BMJ Case Reports|November 1, 2016
Native valve Proteus mirabilis endocarditis: successful treatment of a rare entity formulated by in vitro synergy antibiotic testingCaroline R Brotzki, Kari A Mergenhagen, Zackery P Bulman, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of ResistanceSoon-Ee Cheah, Jian Li, Brian T Tsuji, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2010
Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro modelPhillip J Bergen, Jurgen B Bulitta, Alan Forrest, et al.
International Journal of Antimicrobial Agents|December 28, 2020
Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal PrecisionHubert C Chua, Andy Tse, Nicholas M Smith, et al.
Journal of Biomedical Science|October 31, 2022
Integrated metabolomic and transcriptomic analyses of the synergistic effect of polymyxin-rifampicin combination against Pseudomonas aeruginosaMohd Hafidz Mahamad Maifiah, Yan Zhu, Brian T Tsuji, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosaJürgen B Bulitta, Neang S Ly, Jenny C Yang, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|March 13, 2013
Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing designCornelia B Landersdorfer, Neang S Ly, Hongmei Xu, et al.
The Journal of Antibiotics|June 9, 2016
Impact of Staphylococcus aureus accessory gene regulator (agr) system on linezolid efficacy by profiling pharmacodynamics and RNAIII expressionRachel L Soon, Justin R Lenhard, Irene Reilly, et al.
Diagnostic Microbiology and Infectious Disease|February 6, 2008
Evaluation of daptomycin, telavancin, teicoplanin, and vancomycin activity in the presence of albumin or serumBrian T Tsuji, Steven N Leonard, Paul R Rhomberg, et al.
Annals of Clinical Microbiology and Antimicrobials|May 24, 2011
Impact of accessory gene regulator (agr) dysfunction on vancomycin pharmacodynamics among Canadian community and health-care associated methicillin-resistant Staphylococcus aureusBrian T Tsuji, Robert D MacLean, Linda D Dresser, et al.
BMJ Case Reports|November 1, 2016
Native valve Proteus mirabilis endocarditis: successful treatment of a rare entity formulated by in vitro synergy antibiotic testingCaroline R Brotzki, Kari A Mergenhagen, Zackery P Bulman, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of ResistanceSoon-Ee Cheah, Jian Li, Brian T Tsuji, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2010
Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro modelPhillip J Bergen, Jurgen B Bulitta, Alan Forrest, et al.
International Journal of Antimicrobial Agents|December 28, 2020
Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal PrecisionHubert C Chua, Andy Tse, Nicholas M Smith, et al.
Journal of Biomedical Science|October 31, 2022
Integrated metabolomic and transcriptomic analyses of the synergistic effect of polymyxin-rifampicin combination against Pseudomonas aeruginosaMohd Hafidz Mahamad Maifiah, Yan Zhu, Brian T Tsuji, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosaJürgen B Bulitta, Neang S Ly, Jenny C Yang, et al.
Pageof 11